Company

Stealth BioTherapeutics Inc.

Needham-based Stealth BioTherapeutics Inc. develops therapies for mitochondrial dysfunction, including dry age-related macular degeneration.

About

Founded in 2007 in Needham, US, by Hazel Szeto, Stealth BioTherapeutics Inc. develops therapies for mitochondrial dysfunction, with a focus on dry age-related macular degeneration. Reenie McCarthy is CEO. The company has completed 11 deals since inception, and its most recent round, a Private Placement/Follow on on April 13, 2022, raised USD 4.99 mn. It reported zero revenue in its most recent year and is listed at the Public stage.

4Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in